Stockreport

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company f [Read more]